Presentation ACC 2013 The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study Presenter: Ian T. Meredith March 11, 2013
Presentation ACC 2013 A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort Presenter: Martin B. Leon March 09, 2013
Presentation ACC 2013 STREAM: Strategic Reperfusion Early After Myocardial Infarction Presenter: Frans Van de Werf March 09, 2013
Presentation ACC 2013 One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer Presenter: Masahiro Natsuaki March 09, 2013
Presentation ACC 2013 Stent Design Impacts Geometric Vessel Distortion Following Coronary Artery Stenting in Severely Angulated Lesions: Angiographic Analysis of the PLATINUM Trial Presenter: Jeffrey J. Popma March 09, 2013
Presentation ACC 2013 One Year Outcomes and Resource Utilization in ACRIN PA 4005:Multicenter RCT of Rapid Rule-Out Strategy of CCTA vs Traditional Care Presenter: Judd E. Hollander March 09, 2013
Presentation ACC 2013 Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement Presenter: Philippe Généreux March 09, 2013
Presentation ACC 2013 Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents Presenter: Ian T. Meredith March 09, 2013
Presentation ACC 2013 A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardIal InfarctiON in Real Life: APPOSITION III Study Presenter: Gilles Montalescot March 08, 2013